Skip to main content
SpringerLink
Log in

Clinical and Virological Characteristics Post HBsAg Seroclearance in Hepatitis B Virus Carriers With Hepatic Steatosis Versus Those Without

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

It has been suggested hepatic steatosis contributes to seroclearance of hepatitis B surface antigen (HBsAg) in chronic hepatitis B virus (HBV) infection. Although HBsAg seroclearance generally confers favorable outcome, hepatic steatosis may account for progressive liver fibrosis and cirrhosis. Further studies are needed to compare clinical and virological characteristics post HBsAg seroclearance between subjects with hepatic steatosis and those without.

Methods

One-hundred and fifty-five HBsAg carriers with HBsAg seroclearance were enrolled. Subjects with moderate–severe hepatic steatosis as diagnosed by ultrasonography were designated as having hepatic steatosis.

Results

There were 69 subjects with hepatic steatosis and 86 without. Subjects with hepatic steatosis had significantly higher body mass index (BMI; 27.8 ± 3.5 vs. 23.0 ± 3.1, P < 0.001), were more likely to be male (78.3 vs. 63.9 %, P = 0.05), and were significantly younger at HBsAg seroclearance (48.7 ± 8.9 years vs. 53.4 ± 8.9 years, P = 0.001), than those without. The frequency of anti-HBsAg seroconversion (56.5 vs. 59.3 %, P = 0.72) and HBV viremia (20.3 vs. 15.1 %, P = 0.40) was not significantly different between subjects with and without hepatic steatosis, but the incidence of abnormal AST and ALT was significantly higher in the former (23.2 vs. 0 %, P < 0.0001; and 30.4 vs. 0 %, P < 0.0001, respectively), and progression to liver cirrhosis tended to be more likely in the former than in the latter (10.1 vs. 3.5 %, P = 0.09).

Conclusions

In HBsAg carriers with increased body mass index, hepatic steatosis can accelerate HBsAg seroclearance by approximately 5 years. However, the beneficial effects of HBsAg seroclearance should be balanced against the harmful effects of hepatic steatosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet. 2009;373:582–592.

    Article  PubMed  CAS  Google Scholar 

  2. Hsu YS, Chien RN, Yeh CT, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology. 2002;35:1522–1527.

    Article  PubMed  Google Scholar 

  3. Chu CM, Hung SJ, Lin J, Tai DI, Liaw YF. Natural history of hepatitis be antigen to antibody seroconversion in patients with normal serum aminotransferase levels. Am J Med. 2004;116:829–834.

    Article  PubMed  CAS  Google Scholar 

  4. Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology. 1991;13:627–631.

    Article  PubMed  CAS  Google Scholar 

  5. Chu CM, Liaw YF. HBsAg seroclearance in asymptomatic carriers of high endemic areas: appreciably high rates during a long-term follow-up. Hepatology. 2007;45:1187–1192.

    Article  PubMed  Google Scholar 

  6. Chu CM, Liaw YF. Hepatitis B surface antigen seroclearance during chronic HBV infection. Antivir Ther. 2010;15:133–143.

    Article  PubMed  Google Scholar 

  7. Chu CM, Lin DY, Liaw YF. Does increased body mass index with hepatic steatosis contribute to seroclearance of hepatitis B virus (HBV) surface antigen in chronic HBV infection? Int J Obes (Lond). 2007;31:871–875.

    Google Scholar 

  8. Liu J, Yang HI, Lee MH, et al. Incidence and determinants of spontaneous Hepatitis B surface antigen seroclearance: a community-based follow-up study. Gastroenterology. 2010;139:474–482.

    Article  PubMed  Google Scholar 

  9. Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol. 2011;26:1361–1367.

    PubMed  Google Scholar 

  10. Chen YC, Sheen IS, Chu CM, Liaw YF. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology. 2002;123:1084–1089.

    Article  PubMed  Google Scholar 

  11. Ratziu V, Poynard T. NASH: a hidden and silent fibroser finally revealed. J Hepatol. 2005;42:132–138.

    Article  Google Scholar 

  12. Lin DY, Sheen IS, Chiu CT, Lin SM, Kuo YC, Liaw YF. Clinical significance of ultrasonographical fatty live in asymptomatics: analysis of 1040 check-up subjects. J Med Ultrasound. 1993;1:165–171.

    Google Scholar 

  13. Saverymittu SH, Joseph AEA, Maewell MD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. BMJ. 1986;292:13–15.

    Article  Google Scholar 

  14. Lin DY, Sheen IS, Chiu CT, Lin SM, Kuo YC, Liaw YF. Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study. J Clin Ultrasound. 1993;21:303–308.

    Article  PubMed  CAS  Google Scholar 

  15. Hochberger S, Althof D, de Schrott G, Nachbaur N, Rock H, Leying H. Fully automated quantitation of hepatitis B virus (HBV) DNA in human plasma by the COBAS AmpliPrep/COBAS TaqMan System. J Clin Virol. 2006;35:373–380.

    Article  PubMed  CAS  Google Scholar 

  16. Chu CM, Liaw YF, Sheen IS, Kin DY, Huang MJ. Sex difference in chronic hepatitis B virus infection: an appraisal based on the status of hepatitis B e antigen and antibody. Hepatology. 1983;3:947–950.

    Article  PubMed  CAS  Google Scholar 

  17. Chu CM, Sheen IS, Lin SM, Liaw YF. Sex difference in chronic hepatitis B virus infection: studies of serum HBeAg and alanine aminotransferase levels in 10,431 asymptomatic Chinese HBsAg carriers. Clin Infect Dis. 1993;16:709–713.

    Article  PubMed  CAS  Google Scholar 

  18. Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc. 2006;105:626–635.

    Article  PubMed  Google Scholar 

  19. Huang KC. Obesity and its related diseases in Taiwan. Obes Rev. 2008;9:32–34.

    Article  PubMed  Google Scholar 

  20. Lin YC, Chou SC, Huang PT, Chiou HY. Risk factors and predictors of non-alcoholic fatty liver disease in Taiwan. Ann Hepatol. 2011;10:125–132.

    PubMed  Google Scholar 

  21. Shlomai A, Shaul Y. The “metabolovirus” model of hepatitis B virus nutritional therapy as an effective anti-viral weapon. Med Hypothesis. 2008;71:53–57.

    Article  Google Scholar 

  22. Bar-Yishay I, Shaul Y, Shlomai A. Hepatocyte metabolic signaling pathways and regulation of hepatitis B virus expression. Liver Int. 2011;31:285–290.

    Article  Google Scholar 

  23. Pettinelli P, Del Pozo T, Araya J, et al. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion. Biochim Biophys Acta. 2009;1792:1080–1086.

    Article  PubMed  CAS  Google Scholar 

  24. Furusyo N, Hayashi J, Sawayama Y, Kishihara Y, Kashiwagi S. Hepatitis B surface antigen disappearance and hepatitis B surface antigen subtype: a prospective, long-term, follow-up study of Japanese residents of Okinawa, Japan with chronic hepatitis B virus infection. Am J Trop Med Hyg. 1999;60:616–622.

    PubMed  CAS  Google Scholar 

  25. Manno M, Cammà C, Schepis F, et al. Natural history of chronic HBV carriers in northern Italy: morbidity and mortality after 30 years. Gastroenterology. 2004;127:756–763.

    Article  PubMed  Google Scholar 

  26. Ahn SH, Park YN, Park JY, Chang HY, et al. Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. J Hepatol. 2005;42:188–194.

    Article  PubMed  CAS  Google Scholar 

  27. Yuen MF, Wong DK, Fung J, et al. HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology. 2008;135:1192–1199.

    Article  PubMed  CAS  Google Scholar 

  28. Loriot MA, Marcellin P, Walker F, et al. Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol. 1997;27:251–258.

    Article  PubMed  CAS  Google Scholar 

  29. Arase Y, Ikeda K, Suzuki F, et al. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B. Am J Med. 2006;119:71.e9–71.e16.

    Article  Google Scholar 

  30. Arase Y, Suzuki F, Suzuki Y, et al. Long-term presence of HBV in the sera of chronic hepatitis B patients with HBsAg seroclearance. Intervirology. 2007;50:161–165.

    Article  PubMed  CAS  Google Scholar 

  31. Chu CM, Liaw YF. Prevalence of and risk factor for hepatitis B viremia after spontaneous hepatitis B surface antigen seroclearance in hepatitis B carriers. Clin Infect Dis. 2012;54:88–90.

    Article  PubMed  CAS  Google Scholar 

  32. Wong GL, Wong VW, Choi PC, et al. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut. 2009;58:111–117.

    Article  PubMed  Google Scholar 

  33. Yu MW, Shih WL, Lin CL, et al. Body-mass index and progression of hepatitis B: a population-based cohort study in men. J Clin Oncol. 2008;26:5576–5582.

    Article  PubMed  Google Scholar 

  34. Kumar M, Sarin SK, Hissar S, et al. Virologic and histogic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology. 2008;134:1376–1384.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Lue LH and Shyu WC for their technical assistance. This study was supported by grants from National Science of Council of Taiwan (NSC 97-2314-B-182-019-MY2 and NSC 99-2314-B-182-029-MY3).

Author information

Authors and Affiliations

  1. Liver Research Unit, Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, 199, Tung Hwa North Road, Taipei, 10591, Taiwan

    Chia-Ming Chu, Deng-Yn Lin & Yun-Fan Liaw

Authors
  1. Chia-Ming Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Deng-Yn Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yun-Fan Liaw
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chia-Ming Chu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chu, CM., Lin, DY. & Liaw, YF. Clinical and Virological Characteristics Post HBsAg Seroclearance in Hepatitis B Virus Carriers With Hepatic Steatosis Versus Those Without. Dig Dis Sci 58, 275–281 (2013). https://doi.org/10.1007/s10620-012-2343-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-012-2343-9

Keywords

Search

Navigation